Alpine Global Management’s West Pharmaceutical WST Stock Holding History

Alpine Global Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,007	Closed	-$414K	–	650
2022 Q1	$414K	Buy	+1,007	New	+$394K	0.09%	106
2021 Q2	–	Sell	-2,575	Closed	-$726K	–	374
2021 Q1	$726K	Buy	+2,575	New	+$737K	0.07%	142
2016 Q3	–	Sell	-4,294	Closed	-$326K	–	163
2016 Q2	$326K	Buy	+4,294	New	+$312K	0.15%	67
2014 Q1	–	Sell	-6,565	Closed	-$322K	–	185
2013 Q4	$322K	Buy	+6,565	New	+$307K	0.52%	45

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Alpine Global Management's WST Position: Q2 2022 in Review

Alpine Global Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 1,007 shares — an estimated $414K sold.

Alpine Global Management first reported a position in WST in Q4 2013 and held it in 4 quarters. The position peaked at $726K in Q1 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Alpine Global Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Alpine Global Management sold 1,007 West Pharmaceutical shares in Q2 2022, an estimated $414K.
Alpine Global Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 4 quarters.
Alpine Global Management's West Pharmaceutical position peaked at $726K in Q1 2021.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Alpine Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.